Charles was diagnosed with young-onset Alzheimer’s disease at the age of 63. His daughter, Lauren, shares how dementia ...

The Alzheimer’s Society Forget Me Not Appeal will end the devastation caused by dementia. In support of this aim, our ...

This Dementia Action Week, 19 - 25 May 2025, we will continue to raise awareness of the importance of an early diagnosis for people affected by dementia. Diagnosis is vital to give people access to ...

Reading may seem like a solitary pursuit, but reading groups turn it into a shared pleasure, including for people affected by dementia. Losing yourself in a good story or soaking in the beauty of ...

Advice from forum members and Dementia together magazine readers for when a person with dementia keeps turning things off around the house. It can cause disruption and worry if a relative or friend ...

At Alzheimer’s Society, we're now a proud partner in a £6 million initiative funded by UK Research and Innovation (UKRI) and the National Institute for Health and Care Research (NIHR) to develop ...

Dr Kellyn Lee is a Chartered Psychologist and Research Fellow in Ageing and Dementia. She is also Co-Director of the Alzheimer’s Society funded Doctoral Training Centre – Dementia Care and Founder of ...

There are ways to support a person with dementia when travelling. These will depend on the type of transport being used. People with dementia can have difficulties with planning and remembering the ...

There are many reasons why a person with dementia may need to move to a new care home. For example, their care home may be closing or their dementia may have progressed, so they need more specialist ...

Today the dementia diagnosis rate target (that 66.7% of people living with dementia in England should have a diagnosis) has been removed from the NHS Operational Planning Guidance for 2025-6. Fiona ...

This World Alzheimer’s Month, we have published new data revealing that people living with undiagnosed dementia attend A&E three times more than those without the condition. Dementia costs the UK ...

The MHRA have approved lecanemab for some people with early-stage Alzheimer’s disease. However NICE does not recommend use on the NHS for any patients. Fiona Carragher, Chief Policy and Research ...